These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8051764)

  • 41. [Hemolytic anemia secondary to the placement of a portosystemic stented shunt].
    Carrillo-Esper R; Carrillo-Cortes U; Carrillo-Córdova JR; Carrillo-Córdova LD; Carrillo-Córdova CA; Carrillo-Córdova DM
    Cir Cir; 2013; 81(2):143-7. PubMed ID: 23522316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shunting: a better way to prevent variceal bleeding.
    Pedroso FE; Koniaris LG
    J Surg Res; 2011 May; 167(1):e1-3. PubMed ID: 21324391
    [No Abstract]   [Full Text] [Related]  

  • 43. Massive bleeding from an ileal conduit caput medusae.
    Lo RK; Johnson DE; Smith DB
    J Urol; 1984 Jan; 131(1):114-5. PubMed ID: 6690729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.
    Selim N; Fendley MJ; Boyer TD; Galloway JR; Branum GD
    Ann Surg; 1998 Apr; 227(4):600-3. PubMed ID: 9563552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy in the elective treatment of recurrent variceal bleeding.
    Popovic P; Stabuc B; Skok P; Surlan M
    J Int Med Res; 2010; 38(3):1121-33. PubMed ID: 20819451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Portal hypertension.
    Collini FJ; Brener B
    Surg Gynecol Obstet; 1990 Feb; 170(2):177-92. PubMed ID: 2405526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distal splenorenal shunt: preferred treatment for recurrent variceal hemorrhage in the patient with well-compensated cirrhosis.
    Elwood DR; Pomposelli JJ; Pomfret EA; Lewis WD; Jenkins RL
    Arch Surg; 2006 Apr; 141(4):385-8; discussion 388. PubMed ID: 16618897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial.
    Rosemurgy AS; Frohman HA; Teta AF; Luberice K; Ross SB
    J Am Coll Surg; 2012 Apr; 214(4):445-53; discussion 453-5. PubMed ID: 22463885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention and treatment of variceal haemorrhage in 2017.
    Brunner F; Berzigotti A; Bosch J
    Liver Int; 2017 Jan; 37 Suppl 1():104-115. PubMed ID: 28052623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter: preliminary clinical experience.
    Colapinto RF; Stronell RD; Gildiner M; Ritchie AC; Langer B; Taylor BR; Blendis LM
    AJR Am J Roentgenol; 1983 Apr; 140(4):709-14. PubMed ID: 6601376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Surgical treatment of portal hypertension].
    Wolff M; Hirner A
    Zentralbl Chir; 2005 Jun; 130(3):238-45. PubMed ID: 15965877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Transjugular intrahepatic portosystemic shunt in the treatment of complications in portal hypertension].
    Svoboda P; Kantorová I; Brhelová H; Vasícková J; Ochmann J
    Rozhl Chir; 1997 Feb; 76(2):97-102. PubMed ID: 9213934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiology and treatment of variceal hemorrhage.
    Roberts LR; Kamath PS
    Mayo Clin Proc; 1996 Oct; 71(10):973-83. PubMed ID: 8820773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small-diameter portacaval H-graft shunt: a paradigm shift back to surgical shunting in the management of variceal bleeding in patients with preserved liver function.
    Hillebrand DJ; Kojouri K; Cao S; Runyon BA; Ojogho O; Concepcion W
    Liver Transpl; 2000 Jul; 6(4):459-65. PubMed ID: 10915169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results.
    Richter GM; Noeldge G; Palmaz JC; Roessle M; Slegerstetter V; Franke M; Gerok W; Wenz W; Farthman E
    Radiology; 1990 Mar; 174(3 Pt 2):1027-30. PubMed ID: 2305084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications.
    Brown RS; Lake JR
    Adv Intern Med; 1997; 42():485-504. PubMed ID: 9048128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parastomal ileal conduit hemorrhage and portal hypertension.
    Eckhauser FE; Sonda LP; Strodel WE; Edgcomb LP; Turcotte JG
    Ann Surg; 1980 Nov; 192(5):620-4. PubMed ID: 6969068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study.
    Zheng J; Zhang Y; Li P; Zhang S; Li Y; Li L; Ding H
    BMC Gastroenterol; 2019 Feb; 19(1):32. PubMed ID: 30782139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.